We have had effective means to treat drug-resistant infections for decades!

originally posted by: paraphi
Phage therapy works, but not all the time.

It's another therapy that attracts the blanket belief that it will solve all problems, easily and every time. It won't.

However, it can work, but not all the time.

Thats what R&D is for. If the same amount of resources was put into this as was put into other high profit big pharma pursuits, I'll bet my left nut this would be a non issue.

originally posted by: ReadLeader
a reply to: Mianeye

Same reason they won't use cannabis, or other natural cure-all treatment.

There are several patented cannabis medicines on the market.

There are places that use Phage therapy, you just have to look.

Phage therapy is used broadly in Georgia, which has been the global center of phage expertise for over 80 years. We are the longest operating and most experienced clinic of its kind in Georgia, now entering our tenth year of operation with a success rate exceeding 95%.

Phage Therapy Center and our affiliates have developed novel technologies, methodologies and protocols for treatment of patients with very long term chronic infections. We specialize in treatment of chronic UTI, chronic prostatitis, chronic sinusitis and non-healing wounds. We apply a holistic, integrative approach to treatment of chronic patients. Not only is the infection cleared but also the general health is significantly improved.

We welcome all new patients with acne, bronchitis, bronchiectasis, cystic fibrosis, lung infections, colitis, skin infections, intestinal infections, dysbiosis -- most types of bacterial infections. Please feel free to send us your questions -- our staff are always ready to respond. We look forward to receiving you as our patient!

Phage Therapy Center in Georgia





Special Phage Services then merged with AmpliPhi bio sciences in 2012

Advancing Bacteriophage for the Treatment of Bacterial Infections

AmpliPhi Biosciences Corporation is advancing the fight against antibiotic resistance through the development of innovative antibacterial solutions. We invite you to learn more about our proprietary bacteriophage technology and the promise it holds for combating critical health issues facing society.

Latest news from AmpliPhi Bio Sciences

February 9th 2016

AmpliPhi Biosciences Announces Award of Federal Research Grant from Australia to its Collaboration Partner, Westmead Institute

Category: Latest News

AmpliPhi Biosciences Announces Award of Federal Research Grant from Australia to its Collaboration Partner, Westmead Institute

Funds intended to develop new bacteriophage therapeutics for serious infections caused by E. Coli and Klebsiella

San Diego, CA, Sydney, Australia, February 9, 2016 – AmpliPhi Biosciences Corporation (NYSEMKT: APHB), a global leader in developing bacteriophage-based antibacterial therapies to treat drug-resistant infections, congratulates the Westmead Institute’s Centre for Infectious Diseases and Microbiology for winning an AUD $860,000 grant from the Australian Government to isolate and develop phages that target two serious human pathogens, E. Coli and Klebsiella. AmpliPhi will participate in the project by providing its proprietary expertise in bacteriophage isolation, characterization and manufacturing scale-up

www.ampliphibio.com...

Also in Poland:

Institute of Immunology and Experimental Therapy Polish Academy of Sciences

THERAPEUTIC USE OF BACTERIOPHAGES IN BACTERIAL INFECTIONS

Common use of antibiotics in the developed world has resulted in the emergence of bacterial strains, which are highly resistant to virtually all available antimicrobial agents (Nature 2002, 418, 469). As a result, in most infections induced by such bacteria even intensive antibiotic therapy is ineffective. This creates a serious therapeutic problem. Therefore, we observe a growing interest in the use of bacteriophages in medical practice. Since 1980 the specific bacteriophages have been used in our Laboratory for the treatment of over 1500 patients with suppurative bacterial infections, in which a routine antibiotic therapy failed. The results obtained so far showed that phage therapy is safe and highly effective (the majority of patients were cured). Phage therapy may be applied to all patients from whom isolated bacterial strains show full sensitivity to specific phages. Of particular importance is that two pathogens: Staphylococcus aureus and Pseudomonas aeruginosa, which most frequently cause infections, were found to be sensitive to specific phages in more than 80% of cases.

Our Laboratory possesses over 300 specific bacteriophage strains active against Staphylococcus aureus, Escherichia, Klebsiella, Enterobacter, Proteus and Pseudomonas.

We offer:

isolation and identification of bacterial strains from the specimens of patients,
determination of sensitivity of the isolated strains to specific bacteriophages,
preparation of phage lysates for a therapeutic treatment.

www.iitd.pan.wroc.pl...